ONPH (Oncology Pharma) Other Stockholders Equity: $-0.00 Mil (As of Dec. 2004)


What is Oncology Pharma Other Stockholders Equity?

Oncology Pharma ONPH Other Stockholders Equity is $-0.00 Mil as of Dec. 2004.

Oncology Pharma's Other Stockholders Equity for the quarter that ended in Dec. 2004 was $-0.00 Mil.

Oncology Pharma's quarterly Other Stockholders Equity increased from Jun. 2004 ($-0.00 Mil) to Sep. 2004 ($-0.00 Mil) but then declined from Sep. 2004 ($-0.00 Mil) to Dec. 2004 ($-0.00 Mil).

Oncology Pharma's annual Other Stockholders Equity declined from Mar. 2001 ($0.00 Mil) to Mar. 2002 ($-0.00 Mil) but then increased from Mar. 2002 ($-0.00 Mil) to Mar. 2003 ($0.00 Mil).

Oncology Pharma Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Other Stockholders Equity Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Other Stockholders Equity
Get a 7-Day Free Trial -0.20 0.00 0.00 -0.00 0.00

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -0.00 -0.00 -0.00

Oncology Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Oncology Pharma (ONPH) has a Other Stockholders Equity of $-0.00 Mil as of Dec. 2004. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Oncology Pharma and its competitors.
Is Oncology Pharma's Other Stockholders Equity too high?
Oncology Pharma's current Other Stockholders Equity is $-0.00 Mil.
How does Oncology Pharma's Other Stockholders Equity compare to TAUG and IMUN?
Oncology Pharma's Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Diversified Financial Services company?
A good Other Stockholders Equity depends on the Diversified Financial Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Oncology Pharma and its competitors. Oncology Pharma's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Other Stockholders Equity is $-0.00 Mil as of Dec. 2004. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.